UB Paderborn / Katalog / Suche / in CDI

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)

British journal of dermatology (1951), 2021-03, Vol.184 (3), p.437-449

2021

Volltextzugriff (PDF)

Quality of life’ evaluation for individuals with enduring mental illness transitioning from institutional residential care to supported community living arrangements

European psychiatry, 2021-04, Vol.64 (S1), p.S710-S710

2021

Volltextzugriff (PDF)

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

British journal of dermatology (1951), 2020-08, Vol.183 (2), p.242-255

2020

Volltextzugriff (PDF)

Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia

Diabetic medicine, 2007-05, Vol.24 (5), p.481-485

2007

Volltextzugriff (PDF)

Anti‐IL17A, Ixekizumab, for treatment‐resistant chronic venous leg ulcers: A phase II randomized, double‐blind, placebo‐controlled pilot trial

Journal of the European Academy of Dermatology and Venereology, 2023-08, Vol.37 (8), p.e973-e975

2023

Volltextzugriff (PDF)

Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long‐term results from a randomized controlled, double‐blind, 52‐week, phase III trial in patients with moderate‐to‐severe plaque psoriasis

British journal of dermatology (1951), 2017-12, Vol.177 (6), p.1562-1574

2017

Volltextzugriff (PDF)

Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial

British journal of dermatology (1951), 2014-11, Vol.171 (5), p.1164-1171

2014

Volltextzugriff (PDF)

An indirect comparison of long‐term efficacy of every‐2‐week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12

British journal of dermatology (1951), 2020-07, Vol.183 (1), p.52-59

2020

Volltextzugriff (PDF)

Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials

The Journal of dermatological treatment, 2022-01, Vol.33 (1), p.219-228

2022

Volltextzugriff (PDF)

Secukinumab-Induced Inflammatory Bowel Disease in a Patient Treated for Chronic Plaque Psoriasis and Psoriatic Arthritis: A Case Report and Review of the Role of Novel Biologic Agents Targeting the p19 Subunit of IL-23

Case reports in medicine, 2020-08, Vol.2020, p.1-6

2020

Volltextzugriff (PDF)

Biosimilars: what the dermatologist should know

Journal of the European Academy of Dermatology and Venereology, 2018-07, Vol.32 (7), p.1066-1074

2018

Volltextzugriff (PDF)

Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities

British journal of dermatology (1951), 2008-05, Vol.158 (5), p.994-999

2008

Volltextzugriff (PDF)

Quality of life and social functioning of former long-stay psychiatric patients transferred into the community: a 10 year follow up study

Social Psychiatry and Psychiatric Epidemiology, 2018-08, Vol.53 (8), p.795-801

2018

Volltextzugriff (PDF)

Alcidamas and the Idea of Literary History: P. Mich. Inv. 2754

Classical philology, 2023-10, Vol.118 (4), p.440-458

Spelman, Henry L.

2023

Volltextzugriff (PDF)

Clinical utility of skin cancer and melanoma risk scores for population screening: TRoPICS study

Journal of the European Academy of Dermatology and Venereology, 2021-05, Vol.35 (5), p.1094-1098

2021

Volltextzugriff (PDF)

Hidradenitis Suppurativa Recurrence in a Caesarean Scar

Case reports in obstetrics and gynecology, 2020, Vol.2020, p.1-4

2020

Volltextzugriff (PDF)

A reply to ‘Efficacy and safety of widefield radiation therapy for extensive skin field cancerization remains unproven’

JEADV clinical practice, 2024-06, Vol.3 (2), p.749-750

2024

Volltextzugriff (PDF)

Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice

Journal of the European Academy of Dermatology and Venereology, 2015-11, Vol.29 (11), p.2184-2191

2015

Volltextzugriff (PDF)

THE VIEW FROM OLYMPUS: THE MUSES’ SONG IN THE HOMERIC HYMN TO APOLLO

Classical quarterly, 2020-05, Vol.70 (1), p.1-9

Spelman, Henry L.

2020

Volltextzugriff (PDF)

Efficacité du guselkumab par rapport au sécukinumab chez les patients atteints de psoriasis en plaques modéré à sévère selon les traitements antérieurs du psoriasis : résultats de l’étude ECLIPSE

Annales de dermatologie et de vénéréologie, 2019-12, Vol.146 (12), p.A341-A341

2019

Volltextzugriff (PDF)

Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma

British journal of dermatology (1951), 2005-04, Vol.152 (4), p.765-772

2005

Volltextzugriff (PDF)

Persistance de l’amélioration clinique du psoriasis génital après un an de traitement par ixékizumab : résultats d’une étude clinique de phase 3 randomisée contrôlée versus placebo chez des patients atteints de psoriasis génital modéré à sévère (IXORA-Q)

Annales de dermatologie et de vénéréologie, 2019-12, Vol.146 (12), p.A348-A349

2019

Volltextzugriff (PDF)

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study

The Journal of dermatological treatment, 2003, Vol.14 (2), p.99-106

2003

Volltextzugriff (PDF)

1513 Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: A phase II randomized, double-blind, placebo-controlled pilot trial

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S259-S259

2023

Volltextzugriff (PDF)

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

The New England journal of medicine, 2014-07, Vol.371 (4), p.326-338

2014

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)

Quality of life’ evaluation for individuals with enduring mental illness transitioning from institutional residential care to supported community living arrangements

Baricitinib in patients with moderate‐to‐severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials

Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia

Anti‐IL17A, Ixekizumab, for treatment‐resistant chronic venous leg ulcers: A phase II randomized, double‐blind, placebo‐controlled pilot trial

Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long‐term results from a randomized controlled, double‐blind, 52‐week, phase III trial in patients with moderate‐to‐severe plaque psoriasis

Daylight photodynamic therapy with methyl aminolevulinate cream as a convenient, similarly effective, nearly painless alternative to conventional photodynamic therapy in actinic keratosis treatment: a randomized controlled trial

An indirect comparison of long‐term efficacy of every‐2‐week dosing vs. recommended dosing of ixekizumab in patients who had static Physician's Global Assessment > 1 at week 12

Disease activity and treatment efficacy using patient-level Psoriasis Area and Severity Index scores from tildrakizumab phase 3 clinical trials

Secukinumab-Induced Inflammatory Bowel Disease in a Patient Treated for Chronic Plaque Psoriasis and Psoriatic Arthritis: A Case Report and Review of the Role of Novel Biologic Agents Targeting the p19 Subunit of IL-23

Biosimilars: what the dermatologist should know

Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities

Quality of life and social functioning of former long-stay psychiatric patients transferred into the community: a 10 year follow up study

Alcidamas and the Idea of Literary History: P. Mich. Inv. 2754

Clinical utility of skin cancer and melanoma risk scores for population screening: TRoPICS study

Hidradenitis Suppurativa Recurrence in a Caesarean Scar

A reply to ‘Efficacy and safety of widefield radiation therapy for extensive skin field cancerization remains unproven’

Frequency of undiagnosed psoriatic arthritis among psoriasis patients in Australian dermatology practice

THE VIEW FROM OLYMPUS: THE MUSES’ SONG IN THE HOMERIC HYMN TO APOLLO

Efficacité du guselkumab par rapport au sécukinumab chez les patients atteints de psoriasis en plaques modéré à sévère selon les traitements antérieurs du psoriasis : résultats de l’étude ECLIPSE

Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma

Persistance de l’amélioration clinique du psoriasis génital après un an de traitement par ixékizumab : résultats d’une étude clinique de phase 3 randomisée contrôlée versus placebo chez des patients atteints de psoriasis génital modéré à sévère (IXORA-Q)

A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix®) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study

1513 Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: A phase II randomized, double-blind, placebo-controlled pilot trial

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Suchergebnisse filtern